ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Madrid, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Kidney Diseases
Obesity

Diabetes trials near Madrid, MD, ESP:

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes (DIAGNODE-3)

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Madrid, Spain and 59 other locations

This is a multi-center, prospective, open label study of the Duodenal Glycemic Control™ procedure on type 2 diabetes patients sub-optimally ...

Enrolling
Diabetes Mellitus, Type 2
Device: DiaGone™
Digma Medical

Madrid, Spain and 4 other locations

as adjunctive to non-surgical periodontal therapy in patients with diabetes. The null hypothesis is that the adjunctive use of this probioti...

Enrolling
Diabetes
Periodontitis
Procedure: Scaling and root planing
Other: Probiotic
Universidad Complutense de Madrid

Madrid, Spain

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Madrid, Madrid, Comunidad De, Spain and 651 other locations

The goal of this study is to determine if treatment with TCD601 improves beta-cell function in adults recently diagnosed with type 1 diabetes...

Enrolling
Diabetes Mellitus, Type 1
Biological: TCD601
Other: Placebo

Phase 2

ITBMed

Segovia, Spain and 37 other locations

in people with peripheral arterial disease (PAD) and type 2 diabetes. Participants will either get semaglutide or placebo ("dummy") medicine...

Active, not recruiting
Diabetes Mellitus, Type 2
Peripheral Arterial Disease
Drug: Placebo (semaglutide)
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Madrid, Spain and 124 other locations

The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease. Part...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Pozuelo de Alarcon, Spain and 468 other locations

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants w...

Enrolling
Type 2 Diabetes
Overweight
Drug: Placebo
Drug: Retatrutide

Phase 3

Lilly
Lilly

Madrid, Madrid, Comunidad De, Spain and 103 other locations

index of 27 kg/m² or more. People can take part if they have type 2 diabetes and if they are currently being treated only with diet and exer...

Active, not recruiting
Diabetes Mellitus, Type 2
Obesity
Drug: Survodutide
Drug: Placebo

Phase 3

Boehringer Ingelheim
Boehringer Ingelheim

Madrid, Spain and 142 other locations

The study medicine will be investigated in participants with type 2 diabetes. Participants will either get insulin icodec or insulin glargin...

Enrolling
Diabetes, Type 2
Drug: Insulin glargine
Drug: Insulin icodec

Phase 3

Novo Nordisk
Novo Nordisk

Pozuelo de Alarcón, Spain and 70 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems